Division of Medicinal Chemistry and Natural Products, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
J Biol Chem. 2010 May 7;285(19):14504-13. doi: 10.1074/jbc.M110.104166. Epub 2010 Feb 24.
Heparanase is a promising anticancer target because of its involvement in cancer invasion and metastasis. Heparanase cleaves heparan sulfate (HS), a sulfated polysaccharide, and activates a series of HS-mediated cell proliferation and angiogenesis processes. Understanding the substrate specificity of heparanase will aid the discovery of heparanase inhibitors. Here, we sought to determine the specificity of heparanase using synthetic polysaccharide substrates. The substrates were prepared using purified HS biosynthetic enzymes. Using these substrates, we were able to dissect the structural moieties required for heparanase. Our data suggest that heparanase cleaves the linkage between a GlcA unit and an N-sulfo glucosamine unit carrying either a 3-O-sulfo or a 6-O-sulfo group. In addition, heparanase cleaves the linkage of a GlcA unit and N-sulfo glucosamine unit with a 2-O-sulfated GlcA residue, not a 2-O-sulfated IdoA residue, in proximity. We also discovered that the polysaccharide with repeating disaccharide units of IdoA2S-GlcNS inhibits the activity of heparanase. Our findings advance the understanding of the substrate specificity of heparanase and identify a lead compound for developing polysaccharide-based heparanase inhibitors.
肝素酶是一种很有前途的抗癌靶点,因为它参与了癌症的侵袭和转移。肝素酶能裂解硫酸乙酰肝素 (HS),一种硫酸化多糖,并激活一系列 HS 介导的细胞增殖和血管生成过程。了解肝素酶的底物特异性将有助于发现肝素酶抑制剂。在这里,我们试图使用合成多糖底物来确定肝素酶的特异性。这些底物是使用纯化的 HS 生物合成酶制备的。使用这些底物,我们能够剖析肝素酶所需的结构部分。我们的数据表明,肝素酶裂解带有 3-O-磺酸基或 6-O-磺酸基的 GlcA 单元和 N-磺基葡萄糖胺单元之间的键。此外,肝素酶还能在附近裂解带有 2-O-磺酸化 GlcA 残基而非 2-O-磺酸化 IdoA 残基的 GlcA 单元和 N-磺基葡萄糖胺单元之间的键。我们还发现,具有 IdoA2S-GlcNS 重复二糖单元的多糖能抑制肝素酶的活性。我们的发现推进了对肝素酶底物特异性的理解,并确定了一种用于开发基于多糖的肝素酶抑制剂的先导化合物。